Search Within

Benjamin H Lok

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Pathology and Laboratory Medicine (7)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (5)
  5. Radiation Oncology, Department of (5)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)

More Groups

People
  1. Charles Rudin (3)
  2. Nancy Lee (3)
  3. Simon Powell (3)
  4. Ai Ni (2)
  5. David Pfister (2)
  6. Dennis Kraus (2)

More People

Years
  1. 2018 (1)
  2. 2017 (4)
  3. 2012 (1)
  4. 2011 (1)
Publications
  1. Annals of Surgical Oncology (1)
  2. Cancer (1)
  3. Cancer Cell (1)
  4. Clinical Cancer Research (1)
  5. International Journal of Radiation Oncology, Biology, Physics (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Elsevier Inc. (1)
  5. Impact Journals (1)
  6. Springer (1)

More Publishers

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of an in situ component on outcome after in-breast tumor recurrence in patients treated with breast-conserving therapy
    Journal Article

    Laird, J.; Lok, B.; Siu, C.; Cahlon, O.; Khan, A. J.; McCormick, B.; Powell, S. N.; Cody, H.; Wen, H. Y.; Ho, A.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies
    Meeting Abstract

    Offin, M.; Olah, Z. T.; Sabari, J. K.; Tandon, N.; Feldman, D.; Abou-Alfa, G. K.; Lok, B. H.; Burck, N.; Tarcic, G.; Miron, B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM
    Journal Article

    Ma, J.; Setton, J.; Morris, L.; Albornoz, P. B. C.; Barker, C.; Lok, B. H.; Sherman, E.; Katabi, N.; Beal, K.; Ganly, I.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • PARP Inhibitor activity correlates with SLFN11 expression and demonstrates synergy with temozolomide in small cell lung cancer
    Journal Article

    Lok, B. H.; Gardner, E. E.; Schneeberger, V. E.; Ni, A.; Desmeules, P.; Rekhtman, N.; De Stanchina, E.; Teicher, B. A.; Riaz, N.; Powell, S. N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis
    Journal Article

    Gardner, E. E.; Lok, B. H.; Schneeberger, V. E.; Desmeules, P.; Miles, L. A.; Arnold, P. K.; Ni, A.; Khodos, I.; de Stanchina, E.; Nguyen, T.; more...
    Cancer Cell (2017)

    Fulltext@MSK | Save
  • Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma
    Journal Article

    Lok, B.; Khan, S.; Mutter, R.; Liu, J.; Fields, R.; Pulitzer, M.; Shi, W.; Zhang, Z.; Kraus, D.; Pfister, D.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Selective radiotherapy for the treatment of head and neck merkel cell carcinoma
    Meeting Abstract

    Lok, B.; Khan, S.; Mutter, R.; Fields, R.; Kraus, D.; Pfister, D.; Busam, K.; Brownell, I.; Coit, D.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save